TY - JOUR
T1 - Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months
T2 - A randomized clinical trial
AU - Senders, Angela
AU - Hanes, Douglas
AU - Bourdette, Dennis
AU - Carson, Kimberly
AU - Marshall, Lynn M.
AU - Shinto, Lynne
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding was received from the U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences (UL1 RR024140) and the U.S. Department of Health and Human Services, National Institutes of Health, National Center for Complementary and Integrative Health (K23AT008211).
Publisher Copyright:
© The Author(s), 2018.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Background: Mindfulness training is often used as a therapeutic intervention to manage stress and enhance emotional well-being, yet trials for multiple sclerosis (MS) are limited and few have used an active control. Objective: Assess the feasibility of mindfulness-based stress reduction (MBSR) for people with MS and evaluate the efficacy of MBSR compared to an education control. Methods: We conducted a single-blind, randomized trial of MBSR versus education control among 62 adults with MS. Primary outcomes were measures of feasibility. Secondary outcomes included perceived stress, anxiety, depression, fatigue, pain, resilience, and the Paced Auditory Serial Addition Test, assessed at baseline, 8 weeks, and 12 months. Mean scores for secondary outcome measures were compared between groups at each time point and within groups across time by analyses of covariance or paired t-tests, respectively. Results: Successful recruitment and retention demonstrated feasibility. Improvements in several secondary outcomes were observed among both MBSR and control groups. However, differences between the groups were not statistically significant at either 8 weeks or 12 months. Conclusion: Emotional well-being improved with both MBSR and education. Spontaneous improvement cannot be ruled out as an explanation for findings and additional studies that evaluate the impact of mindfulness training to improve emotional health are warranted.
AB - Background: Mindfulness training is often used as a therapeutic intervention to manage stress and enhance emotional well-being, yet trials for multiple sclerosis (MS) are limited and few have used an active control. Objective: Assess the feasibility of mindfulness-based stress reduction (MBSR) for people with MS and evaluate the efficacy of MBSR compared to an education control. Methods: We conducted a single-blind, randomized trial of MBSR versus education control among 62 adults with MS. Primary outcomes were measures of feasibility. Secondary outcomes included perceived stress, anxiety, depression, fatigue, pain, resilience, and the Paced Auditory Serial Addition Test, assessed at baseline, 8 weeks, and 12 months. Mean scores for secondary outcome measures were compared between groups at each time point and within groups across time by analyses of covariance or paired t-tests, respectively. Results: Successful recruitment and retention demonstrated feasibility. Improvements in several secondary outcomes were observed among both MBSR and control groups. However, differences between the groups were not statistically significant at either 8 weeks or 12 months. Conclusion: Emotional well-being improved with both MBSR and education. Spontaneous improvement cannot be ruled out as an explanation for findings and additional studies that evaluate the impact of mindfulness training to improve emotional health are warranted.
KW - Multiple sclerosis
KW - anxiety
KW - mindfulness
KW - psychological stress
KW - quality of life
KW - resilience
UR - http://www.scopus.com/inward/record.url?scp=85049926390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049926390&partnerID=8YFLogxK
U2 - 10.1177/1352458518786650
DO - 10.1177/1352458518786650
M3 - Article
C2 - 29985095
AN - SCOPUS:85049926390
SN - 1352-4585
VL - 25
SP - 1178
EP - 1188
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 8
ER -